{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:48:06Z","timestamp":1790365686413,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We evaluated temporal trends in survival of Swedish acute myeloid leukemia (AML) patients diagnosed between 1973 and 2011 using relative survival ratios (RSRs) and a measure called the loss in expectation of life (LEL). RSRs increased most for patients &lt;60 years at diagnosis during the first calendar periods, but between 1997\u20132005 and 2006\u20132011 the most pronounced increase was for those aged 61\u201370 years at diagnosis; RSR changed from 0.16 (95% confidence interval (CI): 0.13\u20130.19) to 0.28 (95% CI: 0.23\u20130.33), respectively. The LEL for males aged 35 years at diagnosis was 41.0 (95% CI: 40.1\u201341.8) years in 1975 and 19.5 (95% CI: 16.4\u201322.5) years in 2011. For males aged 65 years, the corresponding figures were 13.8 (95% CI: 13.7\u201314.0) and 12.0 (95% CI: 11.3\u201312.8). Conditional LEL estimates suggested that patients who survive 5 years postdiagnosis have shorter remaining lifespan than the general population. The proportion of expected life lost (PELL) suggested that male 65-year-old patients lost 75% of their life expectancy in 2005 and 66% if they were diagnosed in 2011. Survival continued to increase to 2011, with larger improvements in those aged 61\u201370 years at diagnosis. The LEL and PELL are intuitive measures that may be useful in communicating survival statistics to patients, clinicians and health-care providers.<\/jats:p>","DOI":"10.1038\/bcj.2016.3","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T14:20:58Z","timestamp":1454682058000},"page":"e390-e390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life"],"prefix":"10.1038","volume":"6","author":[{"given":"H","family":"Bower","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M-L","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P W","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P C","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5 R","family":"Derolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"BFbcj20163_CR1","unstructured":"National Cancer Institute. Surveillance Epidemiology and End Results. Available from http:\/\/seer.cancer.gov\/faststats\/selections.php?#Output(accessed 17 June 2014).."},{"key":"BFbcj20163_CR2","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","volume":"113","author":"G Juliusson","year":"2009","unstructured":"Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood 2009; 113: 4179\u20134187.","journal-title":"Blood"},{"key":"BFbcj20163_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453\u2013474.","journal-title":"Blood"},{"key":"BFbcj20163_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","volume":"29","author":"A Burnett","year":"2011","unstructured":"Burnett A, Wetzler M, Lowenberg B . Therapeutic advances in acute myeloid leukemia. J Clin Oncol 2011; 29: 487\u2013494.","journal-title":"J Clin Oncol"},{"key":"BFbcj20163_CR5","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1200\/JCO.2007.15.9814","volume":"26","author":"L Maurillo","year":"2008","unstructured":"Maurillo L, Buccisano F, Del Principe MI, Del Poeta G, Spagnoli A, Panetta P et al. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia. J Clin Oncol 2008; 26: 4944\u20134951.","journal-title":"J Clin Oncol"},{"key":"BFbcj20163_CR6","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1200\/JCO.2012.45.9628","volume":"31","author":"M Terwijn","year":"2013","unstructured":"Terwijn M, van Putten WLJ, Kelder A, van der Velden VHJ, Brooimans RA, Pabst T et al. High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON\/SAKK AML 42\u2009A study. J Clin Oncol 2013; 31: 3889\u20133897.","journal-title":"J Clin Oncol"},{"key":"BFbcj20163_CR7","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1200\/JCO.2011.35.0371","volume":"29","author":"J Kronke","year":"2011","unstructured":"Kronke J, Schlenk RF, Jensen KO, Tschurtz F, Corbacioglu A, Gaidzik VI et al. Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian Acute Myeloid Leukemia Study Group. J Clin Oncol 2011; 29: 2709\u20132716.","journal-title":"J Clin Oncol"},{"key":"BFbcj20163_CR8","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1200\/JCO.2010.28.6468","volume":"28","author":"A Corbacioglu","year":"2010","unstructured":"Corbacioglu A, Scholl C, Schlenk RF, Eiwen K, Du JA, Bullinger L et al. Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia. J Clin Oncol 2010; 28: 3724\u20133729.","journal-title":"J Clin Oncol"},{"key":"BFbcj20163_CR9","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1182\/blood-2011-02-337261","volume":"118","author":"RK Hills","year":"2011","unstructured":"Hills RK, Burnett AK . Applicability of a \"Pick a Winner\" trial design to acute myeloid leukemia. Blood 2011; 118: 2389\u20132394.","journal-title":"Blood"},{"key":"BFbcj20163_CR10","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1182\/blood-2008-09-179341","volume":"113","author":"AR Derolf","year":"2009","unstructured":"Derolf AR, Kristinsson SY, Andersson TML, Landgren O, Dickman PW, Bjorkholm M . Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 2009; 113: 3666\u20133672.","journal-title":"Blood"},{"key":"BFbcj20163_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3324\/haematol.12304","volume":"93","author":"D Pulte","year":"2008","unstructured":"Pulte D, Gondos A, Brenner H . Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 2008; 93: 594\u2013600.","journal-title":"Haematologica"},{"key":"BFbcj20163_CR12","unstructured":"The Swedish Cancer Registry. The National Board of Health and Welfare. Cancer Incidence in Sweden 2011. 2012. Available from http:\/\/www.socialstyrelsen.se\/lists\/artikelkatalog\/attachments\/18919\/2012-12-19.pdf(accessed 7 March 2014)."},{"key":"BFbcj20163_CR13","first-page":"101","volume":"6","author":"F Ederer","year":"1961","unstructured":"Ederer F, Axtell LM, Cutler SJ . The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101\u2013121.","journal-title":"Natl Cancer Inst Monogr"},{"key":"BFbcj20163_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2796.2006.01677.x","volume":"260","author":"PW Dickman","year":"2006","unstructured":"Dickman PW, Adami HO . Interpreting trends in cancer patient survival. J Intern Med 2006; 260: 103\u2013117.","journal-title":"J Intern Med"},{"key":"BFbcj20163_CR15","volume-title":"Instructions to IBM 650 Programmers in Processing Survival Computations","author":"F Ederer","year":"1959","unstructured":"Ederer F, Heise H . Instructions to IBM 650 Programmers in Processing Survival Computations, Methodological note No. 10, End Results Evaluation Section National Cancer Institute: Bethesda, MD, USA, 1959."},{"key":"BFbcj20163_CR16","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1002\/sim.5943","volume":"32","author":"TML Andersson","year":"2013","unstructured":"Andersson TML, Dickman PW, Eloranta S, Lambe M, Lambert PC . Estimating the loss in expectation of life due to cancer using flexible parametric survival models. Stat Med 2013; 32: 5286\u20135300.","journal-title":"Stat Med"},{"key":"BFbcj20163_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0021-9681(77)90057-1","volume":"30","author":"M Hakama","year":"1977","unstructured":"Hakama M, Hakulinen T . Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chronic Dis 1977; 30: 585\u2013597.","journal-title":"J Chronic Dis"},{"key":"BFbcj20163_CR18","unstructured":"Swedish Hematology Association. Report from the acute leukemia registry no.6. 2010. Available from http:\/\/www.cancercentrum.se\/PageFiles\/4674\/Blodcancerregistret_rapport_6.pdf (accessed 24 June 2014)."},{"key":"BFbcj20163_CR19","unstructured":"Hoffman R, Benz EJ, Silberstein LE, Heslop H, Weitz J, Anastasi J. Hematology: Basic Principles and Practice, 6th edn. Churchill Livingstone: Philadelphia, PA, USA, 2013, pp 904\u2013912."},{"key":"BFbcj20163_CR20","unstructured":"OECD (2014) Health at a Glance. OECD Publishing: Paris, France, 2014, pp 16\u201319."},{"key":"BFbcj20163_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bjh.12425","volume":"162","author":"A Shah","year":"2013","unstructured":"Shah A, Andersson TM, Rachet B, Bjorkholm M, Lambert PC . Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study. Br J Haematol 2013; 162: 509\u2013516.","journal-title":"Br J Haematol"},{"key":"BFbcj20163_CR22","first-page":"270","volume":"25","author":"J Berkson","year":"1950","unstructured":"Berkson J, Gage RP . Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin 1950; 25: 270\u2013286.","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"BFbcj20163_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.canep.2013.08.014","volume":"37","author":"XQ Yu","year":"2013","unstructured":"Yu XQ, De Angelis R, Andersson TML, Lambert PC, O'Connell DL, Dickman PW . Estimating the proportion cured of cancer: some practical advice for users. Cancer Epidemiol 2013; 37: 836\u2013842.","journal-title":"Cancer Epidemiol"},{"key":"BFbcj20163_CR24","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/leu.2014.113","volume":"28","author":"X Zhang","year":"2014","unstructured":"Zhang X, Zhang Q, Dahlstrom J, Tran AN, Yang B, Gu Z et al. Genomic analysis of the clonal origin and evolution of acute promyelocytic leukemia in a unique patient with a very late (17 years) relapse. Leukemia 2014; 28: 1751\u20131754.","journal-title":"Leukemia"},{"key":"BFbcj20163_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/02841860802247664","volume":"48","author":"L Barlow","year":"2009","unstructured":"Barlow L, Westergren K, Holmberg L, Talback M . The completeness of the Swedish Cancer Register - a sample survey for year 1998. Acta Oncol 2009; 48: 27\u201333.","journal-title":"Acta Oncol"},{"key":"BFbcj20163_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1365-2141.2009.08026.x","volume":"148","author":"TML Andersson","year":"2010","unstructured":"Andersson TML, Lambert PC, Derolf \u00c5R, Kristinsson SY, Eloranta S, Landgren O et al. Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study. Br J Haematol 2010; 148: 918\u2013924.","journal-title":"Br J Haematol"},{"key":"BFbcj20163_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/leu.2011.78","volume":"25","author":"S Lehmann","year":"2011","unstructured":"Lehmann S, Ravn A, Carlsson L, Antunovic P, Deneberg S, Mollgard L et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia 2011; 25: 1128\u20131134.","journal-title":"Leukemia"},{"key":"BFbcj20163_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3324\/haematol.11987","volume":"93","author":"D Messerer","year":"2008","unstructured":"Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008; 93: 826\u2013833.","journal-title":"Haematologica"},{"key":"BFbcj20163_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0305-7372(03)00142-7","volume":"30","author":"A Redaelli","year":"2004","unstructured":"Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL . Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 2004; 30: 103\u2013117.","journal-title":"Cancer Treat Rev"},{"key":"BFbcj20163_CR30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0959-8049(03)00628-2","volume":"40","author":"M Watson","year":"2004","unstructured":"Watson M, Buck G, Wheatley K, Homewood JR, Goldstone AH, Rees JKH et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004; 40: 971\u2013978.","journal-title":"Eur J Cancer"},{"key":"BFbcj20163_CR31","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00277-014-2088-y","volume":"93","author":"E Branvall","year":"2014","unstructured":"Branvall E, Derolf AR, Johansson E, Hultcrantz M, Bergmark K, Bjorkholm M . Self-reported fertility in long-term survivors of acute myeloid leukemia. Ann Hematol 2014; 93: 1491\u20131498.","journal-title":"Ann Hematol"},{"key":"BFbcj20163_CR32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3324\/haematol.2014.104059","volume":"99","author":"T Barbui","year":"2014","unstructured":"Barbui T, Bjorkholm M, Gratwohl A . Cancer survivorship programs: time for concerted action. Haematologica 2014; 99: 1273\u20131276.","journal-title":"Haematologica"},{"key":"BFbcj20163_CR33","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1182\/blood-2010-11-321737","volume":"117","author":"G Juliusson","year":"2011","unstructured":"Juliusson G . Most 70-to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment. Blood 2011; 117: 3473\u20133474.","journal-title":"Blood"},{"key":"BFbcj20163_CR34","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran B, Weisdorf DJ . Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica 2012; 97: 1916\u20131924.","journal-title":"Haematologica"},{"key":"BFbcj20163_CR35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3109\/0284186X.2014.889851","volume":"53","author":"BK Shah","year":"2014","unstructured":"Shah BK, Ghimire KB . Improved survival among older acute myeloid leukemia patients - a population-based study. Acta Oncol 2014; 53: 935\u2013938.","journal-title":"Acta Oncol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj20163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj20163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:05:25Z","timestamp":1672823125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj20163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"alternative-id":["BFbcj20163"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2016.3","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]},"assertion":[{"value":"30 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}